VMDB

What VMDB does

The Veterinary Medicines Directorate (VMDB) is a UK government executive agency, sponsored by the Department for Environment, Food & Rural Affairs (DEFRA), responsible for the regulatory oversight of veterinary medicines in the United Kingdom. Its mandate covers pre-market assessment and authorisation of veterinary biologics and animal vaccines, pharmacovigilance monitoring, adverse event reporting, and publication of public registers for manufacturing and distribution. The agency is headquartered in Addlestone, Surrey, and serves Marketing Authorisation Holders in the animal medicines industry as its primary regulated constituency, with downstream constituencies of farmers, pet owners, and food supply chain stakeholders.

VMDB operates a portfolio of digital services delivered through the GOV.UK platform rather than a commercial product suite. Core products include the Product Information Database (a public lookup for licensed animal medicines), the Veterinary Medicines Digital Service (a pharmacovigilance submission portal for Marketing Authorisation Holders), the VMD Information Hub (a centralised guidance and regulatory resource), the Adverse Event Reporting Portal, the Veterinary Medicines Registers for manufacturers and distributors, and the Veterinary Medicines Guidance Notes (VMGNs). New digital services — including the Adverse Event Reporting Portal, the Online Contact Form, and the Veterinary Medicines Digital Service — were launched in May–July 2026 as part of an ongoing digitisation programme.

VMDB does not operate on a commercial revenue model. It is funded through UK government appropriations and regulatory fees, has no private shareholders, and reports publicly through DEFRA-aligned annual report and accounts. Its strategic posture is increasingly outward-facing, evidenced by a December 2025 Memorandum of Understanding with the Canadian Food Inspection Agency (CFIA) covering joint reviews of veterinary biologics. Leadership comprises CEO Abigail Seager, Deputy CEO/Director of Authorisations Gavin Hall, and non-executive directors Alison White, Laura Catterick, Mike Venables OBE, and David Catlow.

Name

VMDB

Legal name

Veterinary Medicines Directorate

Website

https://vmd.defra.gov.uk

Company type

Private

Operating status

Operating

Short description

VMDB is a UK government executive agency, sponsored by DEFRA, that regulates veterinary medicines in the United Kingdom. It authorises products, monitors pharmacovigilance, and operates digital services for Marketing Authorisation Holders, farmers, pet owners, and food supply stakeholders.

Ownership category

akta.pro rank

Product category

Veterinary Medicines Regulation

akta.pro primary industry

Veterinary Regulatory Authorities (Licensing, Compliance & Enforcement) (HLAMAJAC)

akta.pro secondary industry

Vaccine Pharmacovigilance & Post-Market Surveillance (HLAMAKAN)

Keywords

• Veterinary medicines regulation
• Animal health oversight
• Pharmacovigilance reporting
• Marketing authorisation
• Adverse event monitoring

Headquarters

HQ city

Addlestone

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Distribution channels4 records

Marketing channels6 records

Core offering

The Veterinary Medicines Directorate (VMDB) is a UK government executive agency that provides statutory regulatory oversight of veterinary medicines in the UK. It assesses and authorises animal medicines, monitors adverse events, maintains public registers of licensed products, manufacturers and distributors, and offers digital services for Marketing Authorisation Holders to submit pharmacovigilance reports and manage regulatory compliance. Its mission is to protect animal health, public health and the environment by ensuring veterinary medicines meet safety, efficacy and quality standards.

Product overview

The Veterinary Medicines Directorate (VMDB) is a UK government regulatory agency that operates a portfolio of digital services and informational products rather than a commercial product suite. The core offerings include the Product Information Database for verifying licensed animal medicines, the Veterinary Medicines Digital Service for pharmacovigilance reporting by Marketing Authorisation Holders, the VMD Information Hub for regulatory guidance, and an Online Contact Form for general enquiries. These digital services are complemented by guidance documentation (VMGNs) and public registers for manufacturing and distribution transparency. VMDB functions as an executive agency sponsored by the Department for Environment, Food & Rural Affairs (DEFRA), focused on protecting animal health, public health, and the environment through regulatory oversight.

Differentiator

Problem solved

Functional benefit

Products and services

• Product Information Database Public database service that allows users to check whether an animal medicine is licensed in the UK. It is targeted at pet owners, farmers, veterinarians and the animal medicines industry needing to verify the authorised status of veterinary products.
• Veterinary Medicines Digital Service Digital service platform enabling Marketing Authorisation Holders to submit pharmacovigilance reports and manage regulatory compliance workflows with the UK veterinary medicines regulator.
• VMD Information Hub Centralised online hub providing regulatory guidance, regulations and resources related to veterinary medicines in the UK for Marketing Authorisation Holders, veterinarians and the public.
• Online Contact Form Digital service for general enquiries and contacting the VMD, serving as the main route for communications with the agency.
• Adverse Event Reporting Portal Digital service for reporting problems with animal medicines or animals exposed to human medicine, enabling easier and more efficient adverse event reporting.
• Veterinary Medicines Registers Public registers for manufacturing and distribution of veterinary medicines, providing transparency on authorised manufacturers and distributors operating in the UK.
• Veterinary Medicines Guidance Notes (VMGNs) Detailed guidance documentation on the regulations and rules governing veterinary medicines in the UK, used by industry applicants and regulators.

Quantifiable outcome

• Reduced duplication in regulatory reviews through joint review mechanisms
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Canadian Food Inspection Agency (CFIA)coreStrategic or Co-development Partner · 17 December 2025Official Memorandum of Understanding signed between VMD and CFIA to enhance collaboration on regulatory oversight of veterinary biologics, including animal vaccines. The agreement aims to make pre-market assessment and approval more efficient by sharing scientific expertise, discussing common priorities, and exploring joint reviews to reduce duplication and facilitate access to products.
• Department for Environment, Food & Rural Affairs (DEFRA)coreOthersVMD is an executive agency sponsored by DEFRA. DEFRA is the parent government department providing strategic oversight and policy direction for the Veterinary Medicines Directorate.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• European Medicines Agency (EMA): EU-level regulator for human and veterinary medicines. EMA is comparable to VMD because both authorize and oversee veterinary medicinal products, though EMA operates across EU member states rather than just the UK.
• U.S. Food and Drug Administration - Center for Veterinary Medicine (FDA-CVM): U.S. federal regulator for veterinary drugs and medicated feeds. FDA-CVM performs the same statutory authorization, pharmacovigilance, and adverse event oversight functions as VMD, but at US national scale.
• Australian Pesticides and Veterinary Medicines Authority (APVMA): Australian regulator for agricultural chemicals and veterinary medicines. APVMA is comparable as a national veterinary medicines regulator handling product authorisation and adverse event reporting.
• Medicines and Healthcare products Regulatory Agency (MHRA): UK regulator for human medicines and medical devices. MHRA is a peer UK executive agency under the same government ecosystem as VMD, sharing GOV.UK digital infrastructure and DEFRA-adjacent governance models.

Direct peers

• Health Canada - Veterinary Drugs Directorate (VDD): Canadian national authority for veterinary drug approval and oversight. VDD is VMD's most direct peer because both regulate veterinary pharmaceuticals/biologics at the national level and the agencies have an active MOU on biologics collaboration.
• Canadian Food Inspection Agency (CFIA): Canadian regulator for veterinary biologics including animal vaccines. CFIA is a direct peer and counterparty to VMD under their December 2025 MOU on biologics oversight, with overlapping scope in vaccine authorization.

Regional players

• Health Products Regulatory Authority (HPRA) - Ireland: Irish regulator for human and veterinary medicines. HPRA shares historical ties to the UK regulatory framework pre-Brexit and continues to perform similar veterinary drug oversight for the Irish market.
• Federal Office of Consumer Protection and Food Safety (BVL) - Germany: German federal authority for veterinary medicinal product authorization and pharmacovigilance. BVL performs VMD-equivalent functions at the national level within the EU regulatory network.
• Spanish Agency of Medicines and Medical Devices (AEMPS): Spanish national regulator for human and veterinary medicines. AEMPS performs VMD-equivalent veterinary authorisation and pharmacovigilance functions within the EU regulatory network.
• Swissmedic: Swiss national authority for human and veterinary medicines. Swissmedic conducts VMD-comparable authorization and post-market surveillance for veterinary medicinal products in a non-EU jurisdiction.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/vmdgovuk?lang=en-gb
• YouTubeyoutube.com/channel/UC8St_xZ7WHtLvIXgXWNfjXg
• Facebookfacebook.com/VMDGOVUK
• LinkedInlinkedin.com/company/veterinary-medicines-directorate

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VMDB